News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Celgene Beats The Street Again On Earnings And Analysts Couldn’t Be Happier     10/23/2014
Genentech, NewLink Genetics Strike $1 Billion+ Cancer Deal     10/21/2014
Ex-Dendreon Corporation CEO Gold Working On New Cancer Drug Startups     10/14/2014
PRAC Decision On Leukemia Drug Good News For Ariad Pharmaceuticals, Inc., Says Analyst     10/10/2014
Progenics Pharmaceuticals, Inc. Pockets A $40 Million Milestone Payment From Salix Pharmaceuticals, Ltd.     10/7/2014
Merck Serono, Institute Of Cancer Research, Wellcome Trust To Co-Develop Cancer Drugs     10/7/2014
Takeda Pharmaceutical Co. Ltd. Accused Of Putting Actos Profit Ahead Of Safety     10/3/2014
Seattle Genetics, Inc., Takeda Pharmaceutical Co. Ltd.'s Cancer Drug Meets Main Goal In Phase 3 Trial     9/29/2014
Baxter International, Inc. Inks A $970 Million Pact For Merrimack Pharmaceuticals Inc.'s Lead Cancer Drug MM-398     9/25/2014
Amgen Asks FDA For Biologics License For Breakthrough Cancer Drug Blinatumomab     9/24/2014
Soligenix Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million     9/19/2014
Merck KGaA Wants Bids For Cancer Therapy Partners     9/18/2014
Roche Battles Counterfeit Rituxin Vials In Germany     9/15/2014
FDA Approves Merck & Co.'s New-Kind Of Cancer Drug Keytruda     9/8/2014
AbbVie Hands Over $275 Million Upfront For Infinity Pharmaceuticals Inc.’s Blood Cancer Drug; Deal Could Be Worth $805 Million     9/5/2014

Featured Stories
Finally: A Missing Link Between Vitamin D and Prostate Cancer, University of Colorado Study     10/23/2014
Y Chromosome Linked To Cancer And Death Risk In Men, Uppsala Universitet Study     10/23/2014
Drinking Two Sodas A Day Can Age You 4 Years, University of California, San Francisco (UCSF) Study     10/21/2014
Thyroid Carcinoma: Biomarker Reveals Cancer Cause, Helmholtz Zentrum Munchen Study     10/14/2014
Americans Living Longer As Fewer Die From Heart Disease, Cancer, CDC Reveals     10/13/2014
Hormone That Keeps Us Alert Also Suppresses The Spread Of Cancer, Weizmann Institute of Science Reveals     10/9/2014
New Blood Test Shows Who Has And Who May Get Cancer, University Of Bradford Study     10/3/2014
Tattoo Ink Linked To Skin Cancer Risk, PRS Global Open Reveals     9/23/2014
Wild Berry Extract May Boost Effect Of Pancreatic Cancer Drug, University of Southampton Study     9/23/2014
Exercise Boosts Tumor-Fighting Ability Of Chemotherapy, University of Pennsylvania Team Finds     9/22/2014
Angelina Jolie Surgery Sparks Surge In Female Cancer Tests     9/19/2014
Certain Form Of Baldness Linked To Prostate Cancer, National Cancer Institute Study     9/17/2014
UV Light Can Turn Gene Into Source Of Skin Cancers, Stanford University School of Medicine Study     9/10/2014
Prediabetes Increases The Risk Of Cancer By 15 Percent, The First People's Hospital Of Shunde Reveals     9/10/2014
Bras Cause Breast Cancer? Apparently Not, Fred Hutchinson Cancer Research Center Study     9/5/2014

More News
Aduro Biotech Presents Updated Interim Results From Phase 1b Clinical Trial In Mesothelioma At International Mesothelioma Interest Group Conference     10/24/2014
Thermo Fisher Scientific (TMO) Release: New Digital PCR-Based Research Solution Characterizes Hard-To-Detect Cancer Mutations     10/23/2014
TCGA Study Improves Understanding Of Genetic Drivers Of Thyroid Cancer     10/23/2014
Helsinn Release: Data Presented At The International Society Of Paediatric Oncology (SIOP) Congress Show Palonosetron Is A Valuable Option For Treating Pediatric Patients Receiving Moderately To Highly Emetogenic Chemotherapy     10/23/2014
Data Presented At The International Society Of Paediatric Oncology (SIOP) Congress Show Palonosetron Is A Valuable Option For Treating Pediatric Patients Receiving Moderately To Highly Emetogenic Chemotherapy     10/23/2014
TapImmune Inc. (TPIV) Provides Update On Polystart™ Vaccine Platform Applicable To Cancer And Infectious Disease     10/22/2014
PledPharma Release: PLIANT Study Is Fully Recruited And The Final Futility Analysis Approved     10/21/2014
NYU Langone Medical Center Release: New Study Demonstrates Advances In Creating Treatment For Common Childhood Blood Cancer     10/21/2014
Advaxis, Inc. Provides Clinical Update For Phase 1/2 Trial Of ADXS-HPV Immunotherapy Product Candidate In Anal Cancer     10/15/2014
Hanmi Pharmaceutical, Co., Ltd And Collaborative Partner Kinex Pharmaceuticals Announce Preliminary Results From A Phase I Clinical Study (HM-OTE-103) With Oratecan® In Patients With Advanced Cancer     10/15/2014
Cancer Treatment Centers Of America Launches Oncoprez(SM) Fertility Preservation Program For Men And Women Fighting Cancer     10/15/2014
Acceleron Pharma Initiates Phase 1 Clinical Trial With Innovative Muscle Drug ACE-083     10/14/2014
Mologen AG (MOLGF.PK) Presents EnanDIM: A New Generation Of Immunomodulators     10/14/2014
SELLAS Life Sciences Group Selects PPD, Inc. (PPDI) As Its Strategic CRO Partner To Advance Zolpidem And WT1 Cancer Vaccine     10/14/2014
Ipsen (IPN.PA) Announces Positive Results From Phase III Clinical Study Of Decapeptyl® (triptorelin pamoate) 11.25 mg Administered By Subcutaneous Route To Prostate Cancer Patients     10/13/2014

//-->